Penumbra (MEX:PEN) Current Accrued Expense: MXN3,006 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:PEN Penumbra Inc MEX:PEN
88 GF Score
Price MXN4,775.70
GF Value MXN4,919.97
! 2 Warning Signs
View Full Analysis

What is Penumbra Current Accrued Expense?

Penumbra MEX:PEN 88 Current Accrued Expense is MXN3,006 Mil as of Jun. 2026. GuruFocus rates MEX:PEN with a GF Score™ of 88/100 and a GF Value™ of MXN4,919.97. The stock has 2 warning signs investors should review.

Penumbra's Current Accrued Expense for the quarter that ended in Jun. 2026 was MXN3,006 Mil.

Penumbra's quarterly Current Accrued Expense increased from Dec. 2025 (MXN2,380 Mil) to Mar. 2026 (MXN2,733 Mil) and increased from Mar. 2026 (MXN2,733 Mil) to Jun. 2026 (MXN3,006 Mil).

Penumbra's annual Current Accrued Expense increased from Dec. 2023 (MXN1,758 Mil) to Dec. 2024 (MXN2,345 Mil) and increased from Dec. 2024 (MXN2,345 Mil) to Dec. 2025 (MXN2,380 Mil).

Penumbra Current Accrued Expense Historical Data

* Premium members only.

The historical data trend for Penumbra's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Penumbra Current Accrued Expense Chart

Penumbra Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Current Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,047.22 1,893.88 1,758.02 2,344.79 2,379.69

Penumbra Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,153.85 2,279.69 2,379.69 2,732.73 3,005.94
MEX:PEN
88GF Score
Penumbra Inc MEX:PEN
Current Accrued Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Penumbra Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

What does a Current Accrued Expense of MXN3,006 Mil mean?
Penumbra (MEX:PEN) has a Current Accrued Expense of MXN3,006 Mil as of Jun. 2026. Current Accrued Expense records the total amount of accrued expenses. View historical data on Penumbra and its competitors.
Is Penumbra's Current Accrued Expense too high?
Penumbra's current Current Accrued Expense is MXN3,006 Mil. Overall, Penumbra has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does Penumbra's Current Accrued Expense compare to PODD and GMED?
Penumbra's Current Accrued Expense of MXN3,006 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for a Medical Devices & Instruments company?
A good Current Accrued Expense depends on the Medical Devices & Instruments industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on Penumbra and its competitors. Penumbra's current Current Accrued Expense is MXN3,006 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Penumbra stock overvalued right now?
Penumbra (MEX:PEN) has a current Current Accrued Expense of MXN3,006 Mil. The stock's GF Value™ is MXN4,919.97, compared to a current price of MXN4,775.70 — trading 2.9% below its estimated fair value. The current Current Accrued Expense is MXN3,006 Mil. Penumbra's overall GF Score™ is 88/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For Penumbra (MEX:PEN), the current Current Accrued Expense is MXN3,006 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Penumbra (MEX:PEN) Overvalued in 2026?

Based on GuruFocus' analysis, Penumbra stock appears to be undervalued. The current stock price of MXN4,775.70 is trading 2.9% below its estimated GF Value™ of MXN4,919.97.

Key valuation signals for MEX:PEN:

  • Current Accrued Expense: MXN3,006 Mil
  • GF Value™: MXN4,919.97 vs. price of MXN4,775.70 (2.9% below fair value)
  • GF Score™: 88/100 with 2 warning signs

No single metric tells the full story. See the MEX:PEN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Penumbra Business Description

Other Exchanges PEN:USA0P8:Germany
Address 1310 Harbor Bay Parkway, One Penumbra Place, Alameda, CA, USA, 94502
Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.
88GF Score

Get the complete analysis for MEX:PEN

Current Accrued Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN4,775.70
Price
MXN4,919.97
GF Value